Project Grant R01LM014760
Award Date 9/9/25
Completion Date 7/31/29
Dollars Obligated $391K
Federal Agency
Awardee
Federal Grant Program
Assistance Type
Project Grant
Place of Performance
Minnesota, USA
Similar Awards
- This federal Project Grant award from the National Heart, Lung, and Blood Institute (NHLBI), under the Cardiovascular Diseases Research program (CFDA 93.837), provides $477,290 to Mayo Clinic to investigate the underlying behavioral mechanisms that impact a home-based pulmonary rehabilitation program for patients with chronic obstructive pulmonary disease (COPD). The research aims to determine the associations between patterns of physical activity, sedentary behavior, sleep, and cognitive...
- The federal Project Grant award, titled "Adding Inspiratory Muscle Training to Optimize Cardiac Rehabilitation for Heart Failure," is funded by the National Heart Lung and Blood Institute (CFDA 93.837 - Cardiovascular Diseases Research). The $745,851 grant, awarded on September 1, 2025, supports research aimed at improving exercise tolerance and reducing exertional symptoms in patients with heart failure with reduced ejection fraction (HFrEF). The key objectives are to: 1) test if...
- The National Heart, Lung, and Blood Institute (NHLBI), under the Cardiovascular Diseases Research (CFDA 93.837) program, awarded a $310,948 Project Grant to Minnesota Healthsolutions Corporation, a for-profit woman-owned small business, on September 15, 2023. The grant funds the development of an adaptable platform to support patients with behavior change interventions aimed at improving adherence to treatment and prevention for multiple chronic diseases. The platform will utilize remote...
- The National Heart, Lung, and Blood Institute (NHLBI) awarded a $783,801 Project Grant under the Cardiovascular Diseases Research program (CFDA 93.837) to the Cleveland Clinic Lerner College of Medicine of Case Western Reserve University (CCLCM). The grant, titled "Demonstrating the Feasibility of Democratized Push-Button Autonomous Cardiac MRI Exam in Community Family Health Centers (AutoCMR for FHC)", aims to demonstrate the feasibility of using a push-button, time-resolved 3D...
- This $2,394,542 Project Grant award from the National Heart, Lung, and Blood Institute (CFDA 93.837 Cardiovascular Diseases Research) will fund a randomized controlled trial to test the effect of transferring patients resuscitated from out-of-hospital cardiac arrest to a specialty cardiac care center versus usual care. The study aims to: 1) estimate the impact of specialty cardiac care on functional recovery, 2) identify the minimum clinical and operational standards for specialty cardiac arrest...
- This Project Grant award, totaling $136,646, was provided by the National Heart, Lung, and Blood Institute (NHLBI) under the Cardiovascular Diseases Research program (CFDA 93.837) to Duke University. The funding will support a 5-year observational study to assess sex differences in physical activity (PA) participation and maintenance among individuals enrolled in cardiac rehabilitation (CR) programs. The key objectives are to: 1) identify sex differences in PA participation during and after...
- This federal Project Grant award, provided by the National Heart, Lung, and Blood Institute under the Cardiovascular Diseases Research program (CFDA 93.837), aims to apply state-of-the-art methods to evaluate the effectiveness of mechanical circulatory support (MCS) devices in treating acute myocardial infarction complicated by cardiogenic shock (AMI-CS). The $817,358 award, effective from August 19, 2025 to May 31, 2029, will support the following key activities: Appending individual patient...
- This $834,249 Project Grant award from the National Heart, Lung, and Blood Institute (CFDA 93.837 Cardiovascular Diseases Research) supports a comparative study of clinical outcomes, patient experiences, and mechanistic insights between transcatheter and surgical treatment of degenerative mitral regurgitation (DMR). The study aims to provide long-term data on clinical effectiveness, safety, and patient-reported outcomes to inform treatment selection and guide patient care. It will also utilize...
- This federal Project Grant award, valued at $695,997.00 and awarded on Aug 18, 2025, supports research conducted by Mayo Clinic Arizona under the Cardiovascular Diseases Research program (CFDA 93.837) administered by the National Heart, Lung, and Blood Institute. The research aims to investigate the role of the Programmed Cell Death 4 (PDCD4) gene in mitigating doxorubicin-induced cardiotoxicity, a common side effect of anthracycline chemotherapy drugs. The project utilizes a juvenile mouse...
- This federal Project Grant award of $498,576.00 from the National Heart, Lung, and Blood Institute (NHLBI) under the Cardiovascular Diseases Research program (CFDA 93.837) aims to enhance the FAITH! mobile health application to promote cardiovascular health among African Americans. The funding will be used by the small business awardee, Careevolution LLC, in partnership with Mayo Clinic, to analyze participant feedback from a previous clinical trial evaluating the web-based FAITH! app...